Carfilzomib
Carfilzomib (PR-171) is a next generation, irreversible and selective inhibitor of the chymotrypsin-like activity of the proteasome. It displays potent antineoplastic activity.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20 ̊C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6354647-01 0.2 mL
TDRD7, CT (TDRD7, PCTAIRE2BP, Tudor domain-containing protein 7, PCTAIRE2-binding protein, Tudor repeat associator with PCTAIRE 2) (Biotin)
Sign In for Pricing
View Details MBS6354647-02 5x 0.2 mL
TDRD7, CT (TDRD7, PCTAIRE2BP, Tudor domain-containing protein 7, PCTAIRE2-binding protein, Tudor repeat associator with PCTAIRE 2) (Biotin)
Sign In for Pricing
View Details